Ubix Therapeutics
Seoul
About Ubix Therapeutics
Ubix Therapeutics is a research and development company that develops anti-cancer drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $33.5M
- Funding stage: Late Stage Venture
- Last round: Series C (Dec 2024)
- Website: ubixtrx.com
- Phone: +82 2 6335 2475
Industries & Categories
Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/ubix-therapeutics-45998 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.